State of Tennessee, Department of Treasury’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$637K Sell
12,316
-3,174
-20% -$162K ﹤0.01% 1356
2025
Q4
$746K Sell
15,490
-6,132
-28% -$298K ﹤0.01% 1291
2025
Q3
$1.03M Buy
21,622
+8,333
+63% +$336K ﹤0.01% 1184
2025
Q2
$419K Hold
13,289
﹤0.01% 1444
2025
Q1
$435K Hold
13,289
﹤0.01% 1439
2024
Q4
$481K Sell
13,289
-5,062
-28% -$178K ﹤0.01% 1439
2024
Q3
$572K Buy
18,351
+3,629
+25% +$113K ﹤0.01% 1395
2024
Q2
$394K Hold
14,722
﹤0.01% 1461
2024
Q1
$502K Sell
14,722
-10,305
-41% -$307K ﹤0.01% 1388
2023
Q4
$724K Sell
25,027
-1,707
-6% -$45.3K ﹤0.01% 1292
2023
Q3
$737K Sell
26,734
-3,715
-12% -$113K ﹤0.01% 1177
2023
Q2
$915K Sell
30,449
-1,226
-4% -$42.9K ﹤0.01% 1199
2023
Q1
$1.15M Buy
31,675
+240
+0.8% +$9.23K 0.01% 1055
2022
Q4
$1.12M Hold
31,435
0.01% 1079
2022
Q3
$1.06M Buy
31,435
+3,371
+12% +$110K 0.01% 1062
2022
Q2
$812K Sell
28,064
-3,110
-10% -$89.1K ﹤0.01% 1176
2022
Q1
$1.01M Buy
31,174
+3,045
+11% +$93.4K ﹤0.01% 1180
2021
Q4
$820K Hold
28,129
﹤0.01% 1210
2021
Q3
$751K Sell
28,129
-1,816
-6% -$48.7K ﹤0.01% 1231
2021
Q2
$922K Sell
29,945
-4,767
-14% -$146K ﹤0.01% 1189
2021
Q1
$909K Sell
34,712
-7,675
-18% -$215K ﹤0.01% 1155
2020
Q4
$1.07M Buy
42,387
+1,683
+4% +$36.2K ﹤0.01% 1040
2020
Q3
$848K Buy
40,704
+1,435
+4% +$32.6K ﹤0.01% 1003
2020
Q2
$933K Buy
39,269
+4,053
+12% +$89.5K ﹤0.01% 988
2020
Q1
$633K Sell
35,216
-4,469
-11% -$93.9K ﹤0.01% 1040
2019
Q4
$941K Sell
39,685
-2,375
-6% -$57.7K ﹤0.01% 1073
2019
Q3
$1.16M Buy
42,060
+4,235
+11% +$125K 0.01% 1007
2019
Q2
$1.25M Sell
37,825
-1,998
-5% -$68.5K 0.01% 949
2019
Q1
$1.4M Buy
39,823
+1,453
+4% +$54.1K 0.01% 927
2018
Q4
$1.27M Buy
38,370
+2,238
+6% +$96.2K 0.01% 903
2018
Q3
$1.82M Buy
36,132
+1,111
+3% +$54.9K 0.01% 854
2018
Q2
$2.1M Sell
35,021
-1,224
-3% -$63.4K 0.01% 802
2018
Q1
$1.66M Sell
36,245
-3,806
-10% -$159K 0.01% 862
2017
Q4
$1.6M Sell
40,051
-4,361
-10% -$172K 0.01% 922
2017
Q3
$1.78M Sell
44,412
-1,967
-4% -$85.1K 0.01% 882
2017
Q2
$2M Hold
46,379
0.01% 851
2017
Q1
$1.45M Buy
46,379
+6,999
+18% +$188K 0.01% 988
2016
Q4
$994K Hold
39,380
0.01% 1114
2016
Q3
$974K Buy
39,380
+12,650
+47% +$286K ﹤0.01% 1046
2016
Q2
$544K Hold
26,730
﹤0.01% 1218
2016
Q1
$408K Buy
26,730
+630
+2% +$8.22K ﹤0.01% 1259
2015
Q4
$351K Buy
+26,100
New +$404K ﹤0.01% 1290
2015
Q3
Sell
-23,000
Closed -$391K 1182
2015
Q2
$391K Buy
+23,000
New +$327K ﹤0.01% 1300

Other funds holding SUPN

State of Tennessee, Department of Treasury's SUPN Position: Q1 2026 in Review

State of Tennessee, Department of Treasury reduced its Supernus Pharmaceuticals (SUPN) stake by 20% in Q1 2026, selling an estimated $162K and leaving 12,316 shares worth $637K. The position accounts for ﹤0.01% of the portfolio, ranked #1356.

State of Tennessee, Department of Treasury first reported a position in SUPN in Q2 2015 and has held it in 43 quarters since. The position peaked at $2.1M in Q2 2018. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.

  • State of Tennessee, Department of Treasury held 12,316 shares of Supernus Pharmaceuticals worth $637K as of Q1 2026.
  • State of Tennessee, Department of Treasury sold 3,174 Supernus Pharmaceuticals shares in Q1 2026, an estimated $162K.
  • Supernus Pharmaceuticals made up ﹤0.01% of State of Tennessee, Department of Treasury's portfolio in Q1 2026, its #1356 holding.
  • State of Tennessee, Department of Treasury first reported a position in Supernus Pharmaceuticals in Q2 2015 and has held it in 43 quarters since.
  • State of Tennessee, Department of Treasury's Supernus Pharmaceuticals position peaked at $2.1M in Q2 2018.
  • 327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.

Based on State of Tennessee, Department of Treasury's 13F filing for Q1 2026, filed 15 May 2026.